Pharmafile Logo

Promimic appoints CEO

Magnus Larsson succeeds Ulf Brogren at the Swedish firm

Promimic Magnus LarssonGothenburg, Sweden-based Prominic, part of life science investment company Karolinska Development, has appointed Magnus Larsson as its new chief executive officer.

Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development.

He brings over 15 years of sales and marketing leadership experience in the international dental implant industry, including three years at Nobel Biocare as country manager for its Swedish business.

Tord Lendau, chairman of the board at Promimic, said: “We are pleased to welcome Magnus Larsson to the company as chief executive officer.

“Magnus brings valuable global leadership experience and a wide network from his time in the dental implant industry.”

Meanwhile, Promimic’s former chief executive Ulf Brogren is relocating to the US to lead the launch of the company’s North America sales operations from Austin, Texas.

Lendau added: “With this appointment and the launch of Promimic under Mr Brogren’s leadership, we are now in much better position to meet our strategic commitment to our customers in North America and build our business in this important market.”

Article by Rebecca Clifford
1st February 2017
From: Sales
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links